AC IMMUNE SA Weighted Average Exercise Price Of Other Equity Instruments Granted In Share-based Payment Arrangement2019
AC IMMUNE SA (ACIU) reported Weighted Average Exercise Price Of Other Equity Instruments Granted In Share-based Payment Arrangement2019 of 0 CHF/shares for the 12-month period ending 2021-12-31, per its 20-F filed 2022-03-22.
Discontinued › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019 · last filed 2022-03-22
CHF
| Period end | Weighted Average Exercise Price Of Other Equity Instruments Granted In Share-based Payment Arrangement2019 12 month |
|---|---|
| 2020-12-31 | 0.00 CHF 20-F · filed 2021-03-23 |
| 2019-12-31 | 0.00 CHF 20-F · filed 2021-03-23 |
| 2018-12-31 | 9.43 CHF 20-F · filed 2021-03-23 |
| 2017-12-31 | 9.62 CHF 20-F · filed 2020-03-30 |
CHF/shares
| Period end | Weighted Average Exercise Price Of Other Equity Instruments Granted In Share-based Payment Arrangement2019 12 month |
|---|---|
| 2021-12-31 | 0.00 CHF/shares 20-F · filed 2022-03-22 |
| 2020-12-31 | 0.00 CHF/shares 20-F · filed 2022-03-22 |
| 2019-12-31 | 0.00 CHF/shares 20-F · filed 2022-03-22 |
| 2018-12-31 | 9.43 CHF/shares 20-F · filed 2021-03-23 |
| 2017-12-31 | 9.62 CHF/shares 20-F · filed 2020-03-30 |